Enhancement of peritoneal dialysis clearance with docusate sodium  by Dunham, Cindy B. et al.
Kidney International, Vol. 20 (1981), pp. 563—568
Enhancement of peritoneal dialysis clearance
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Enhancement of peritoneal dialysis clearance with docusate sodium. A
study was done in rabbits to determine the effect of docusate sodiuni
(DSS) on the peritoneal clearance of creatinine and urea. Following a
series of control exchanges with a commercially available peritoneal
dialysis solution, three animals in each of four groups received DSS
(0.005%, 0.01%, 0.02%, or 0.04%) in a single exchange, followed by IC
subsequent exchanges of control fluid. Creatinine and urea clearances
were measured for each exchange. Comparison of post-DSS clearances
(exchanges 5 through IS) with pre-DSS baseline values (exchanges I
through 4) showed a mean percent increase in creatinine clearance that
was proportional to the concentration and ranged from 74 to 244%
above baseline. Similarly, urea clearance increased by 79 to 166%. The
effect on both creatinine and urea clearance persisted through the
completion of the dialysis procedure. No animals showed signs of
toxicity from DSS. The mechanism of the DSS effect on clearance is
unknown. Although studies are needed to delineate the mechanism of
the effect and to identify potential toxic effects, the results of this study
indicate that DSS has a significant effect on clearance of both creatinine
and urea.
Augmentation de Ia clearance de dialyse peritonéale par le docusate de
sodium. Une étude a été faite chez le lapin afin d'évaluer l'effet du
docusate de sodium (DSS) sur Ia clearance péritonéale de Ia créatinine
et de I'urée. Aprés une série d'echanges témoins avec une solution
commerciale de dialyse périlonéale trois animaux dans chacun des
quatre groupes a recu du DSS (0,005%, 0,01%, 0,02%, ou 0,04%) dans
un seul echange précédant 10 autres échanges avec du liquide contrôle.
Les clearances de l'urée et de Ia créatinine ont été mesurées pour
chaque échange. La comparison des clearances post-DSS (échanges 5 a
15) avec les valeurs pré-DSS (echanges I a 4) a montré un pourcentage
moyen d'augmentation de La clearance de Ia créatinine proportionnel a
Ia concentration de DSS et allant de 74 a 244% des valeurs basales. Dc
Ia méme façon Ia clearance de l'urée a augmenté de 79 a 166%. L'effet
sur les clearances de Ia créatinine et de l'urée persiste jusqu'a Ia fin de Ia
dialyse. II n'a pas été observe de signe de toxicité du DSS. Le
mécanisme de l'effet du DSS sur Ia clearance n'est pas connu. Bien qu'il
soit nécessaire d'étudier Ic mécanisme de cet effet et d'identifier
d'éventuels effets toxiques les résultats indiquent que le DSS a un effet
significatif sur les clearances de Ia créatinine et de l'urée.
Peritoneal dialysis (PD) has become a recognized form of
therapy for patients with acute and chronic renal failure [1—4]
but so far its use remains limited. PD clearances are inadequate
in some patients due to underlying vascular disease [5—7] and in
others may decline over time for reasons that have not been
defined [81. The inherent limitation to the use of PD even under
the best of circumstances is its inefficiency in the clearance of
low molecular weight solutes compared with hemodialysis [9,
10]. As a consequence, long treatment times are required for
control of uremic symptoms in patients receiving intermittent
peritoneal dialysis (IPD). This problem is lessened to a certain
extent with continuous ambulatory peritoneal dialysis (CAPD)
[11, 12], but low clearances of urea and other small molecular
weight solutes, which continue to be implicated in the patho-
genesis of uremic toxicity, remain a stumbling block to the more
widespread application of both IPD and CAPD.
A number of approaches have been explored in an attempt to
augment peritoneal solute clearance. These include (1) altering
dialysate dwell time, volume, or flow rate [13—161, (2) heating
the dialysate solutions to body temperature [161, (3) using
hypertonic dialysate solutions [17—20]; and (4) adding vasoac-
tive agents [7, 20—29], diuretics [30] and surface active agents
[31] to the dialysate solutions.
One promising area of research has involved the intraperito-
neal administration of pharmacologic agents for the enhance-
ment of clearance. In general, percentage increases in peritone-
al clearance of creatinine seen with intraperitoneal accelerators
range between 5 and 30% [24, 26, 28], although clearances as
high as 50 to 55% above baseline have been reported [23].
Increases in urea clearances have been generally within the
range of 5 to 20% [20, 27, 281, although, as in the case of
creatinine, increases as high as 50% have been seen [23]. With
the intraperitoneal administration of most accelerators tested,
the effect on clearance rapidly disappears when the agent is
removed from the dialysate solution [5, 23, 24, 26].
An earlier study in rabbits demonstrated an increase in the
peritoneal clearance of radioactive urea and phosphate when
docusate sodium (DSS) was added to the dialysate solution.
Results regarding its effect on the peritoneal clearance of
creatinine were, however, equivocal [31]. The present study
was undertaken to examine further the potential value of the
addition of DSS to the dialysis solution during peritoneal
dialysis on the clearance of endogenous creatinine and urea. In
addition, four separate concentrations of DSS (0.005%, 0.0 1%,
0.02%, and 0.04%) were studied to determine whether there is a
dose-response relationship to increasing DSS concentrations.
Methods
Peritoneal dialysis was performed in 12 male New Zealand
Nhite rabbits with normal renal function. To prevent agitation,
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Results
(I)
we gave each animal 50 mg of chlorpromazine hydrochloride Model 150B with 510 nm detector, Altex Scientific Corporation,
i.m. prior to the dialysis procedure and subsequently restrained Berkeley, California). The signal was recorded on a laboratory
them. One animal required an additional dose of chiorproma- recorder (Strip Chart Recorder, No. 7l23A, Hewlett-Packard,
zine during the dialysis procedure due to agitation. San Diego, California).
An area in the anterior midline selected for catheter insertion Creatinine content of the samples was calculated by compari-
was shaved and anesthetized. A pediatric peritoneal dialysis son of peak areas to the peak area of a creatinine standard. DSS
catheter was inserted and sutured into place. The external end did not interfere with the determination of creatinine by this
of the catheter was fitted with polyethylene tubing extending method.
into a 100-mi graduated cylinder placed for collection and Urea concentration in plasma and dialysate was analyzed
measurement of dialysate drainage fluid. with a commercially available Urea Nitrogen (BUN) Rapid
Of the 12 animals studied, 10 animals received IS peritoneal Stat® Kit (Pierce Chemical Company, Rockford, Illinois). Ab-
dialysis exchanges in the following sequence: 4 exchanges of sorbance of the colored reaction product was measured on a
control fluid, 1 exchange of control fluid to which DSS was spectrophotometer (Hitachi-Perkin Elmer 139 UV-VIS Spec-
added, and 10 additional exchanges of control fluid. Two trophotometer, Perkin Elmer Corporation, Newark, Delaware)
animals received one extra exchange during the initial control at a wavelength of 525 nm. Urea nitrogen concentration in each
period because of low drainage volume during the first ex- sample was calculated by comparison of its absorbance with
change. These two animals received DSS in the 6th dialysis that of a urea nitrogen standard. DSS did not interfere with the
exchange, and received only 9 exchanges of control fluid determination of urea nitrogen by this method.
following DSS administration. Mean solute clearances were calculated for each dialysis
Control cycles consisted of a commercially available solution exchange according to the following equation:
containing: 1.5% dextrose, 141 mEq/liter sodium, 101 mEq/liter
chloride, 45 mEq/liter lactate, 3.5 mEq/iiter calcium, and 1.5
mEq/liter magnesium (Dianeal® Peritoneal Dialysis Solution Clearance =
(V0) (CD)
(Cr) (t)
with Dextrose, Travenol Laboratories, Deerfield, Illinois). The
DSS exchange contained DSS in a concentration of 0.005%, where VD is the dialysate drainage volume; CD, the dialysate
0.01%, 0.02%, or 0.04%, prepared by dissolving DSS (docusate solute concentration; Ci,, the mean plasma solute concentration
sodium, USP, American Cyanamid Company, Pearl River, during dialysis; and t, the total dialysis cycle time.
New York) in the standard Dianeal® solution. Three animals The plasma concentrations represent the mean of the three
were dialyzed at each of the four DSS concentrations, measured values in each animal, obtained at the previously
The dialysate exchange volume for each animal was 25 mI/kg described sampling times. Prior to statistical analysis, all clear-
of body wt. The dialysate was warmed to 37° C and instilled ance values (mi/mm) were adjusted for differences in animal
into the peritoneal cavity over 1 mm via sterile syringe. A dwell weight and expressed as mi/mm/kg.
time of 19 mm and a drainage time of 10 mm completed the total Analysis of variance (AN OVA) and Duncan's Multiple Corn-
dialysis cycle time of 30 mm. parison Tests were performed with the statistical package
Blood samples were obtained from the marginal ear vein of "Statistical Analysis System" (SAS) available at the Triangle
each animal prior to the beginning of dialysis, at the end of the Universities Computation Center (TUCC), Research Triangle
control period, and at the completion of dialysis. The samples Park, North Carolina. A P value of less than 0.05 was consid-
were centrifuged, and the plasma was removed. An equal ered significant.
volume of 0.2 M citrate buffer (pH, 6.25) was added to the
plasma, which was then filtered through a 0.22- filter. At the
end of each dialysis exchange, a 10-mi aliquot of the fluid was Individual clearances of creatinine and urea before and after
obtained and filtered undiluted through a 0.22-p. filter. All DSS administration are shown for each animal in Table 1. Mean
plasma and dialysate samples were then either analyzed within clearances of creatinirie and urea for all 12 rabbits are shown for
3 hours for urea and creatinine or frozen at —20° C until the each dialysis exchange in Fig. 1. The mean creatinine clearance
time of assay. before DSS was 0.14 0.01 mi/mm/kg. Following DSS adminis-
Creatinine concentration in plasma and dialysate samples tration during the 5th dialysis exchange, the clearance of
was measured by high-performance liquid chromatography creatinine increased and remained elevated with a mean post-
(HPLC) by a modification of the Jaffe reaction 1321 that DSS clearance of 0.34 0.01 mI/mm/kg. The corresponding
eliminated noncreatinine chromogens. A stainless-steel column changes in urea clearance were 0.18 0.12 mi/mm/kg before
of 4.6mm in I.D. and 25 cm in length was packed with a strong DSS, and 0.37 0.02 mI/mm/kg after DSS. The increases in
cation exchange resin (Aminex A-4®, Bio-Rad Company, Rich- clearance resulting from the addition of DSS to a single dialysis
mond, California). Citrate buffer (0.2 M; pH, 6.25) was pumped exchange persisted throughout the remaining exchanges.
through the column continuously at a rate of 0.5 mI/mm. The Table 2 shows mean creatinine and urea clearances grouped
apparatus was fitted with a loop injector to accept samples of up according to the DSS concentration utilized. The rank order
to 0.5 ml. A solution of sodium picrate (90 ml of saturated increase in mean clearance values for both solutes is apparent.
solution of picric acid plus 10 ml of 0.5 N sodium hydroxide) During the control period, however, mean clearances of mdi-
was added continuously to the column effluent, Solutions were vidual animals (Table 1) of creatinine and urea ranged from 0.09
pumped at a constant rate via an HPLC Pumping System to 0.22 and from 0.06 to 0.33 mI/mm/kg, respectively. This wide
(Glenco Scientific Company, Houston, Texas). The combined range in clearance for both solutes during the control period
solutions were passed through a flow-type colorimeter (Altex necessitated normalization for differences in means among the
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Table 1. Mean control and post-DSS clearance of creatinine and ureaa
aClearances are the means Sn.
bReceived an extra control exchange and one less post-DSS exchange
Percent changes in creatinine and urea clearances were
computed for individual dialysis exchanges for each rabbit.
Mean percent changes in creatinine and urea clearance were
subsequently grouped according to concentration for determi-
nation of the influence of DSS concentration on clearance.
Figures 2 and 3 show mean percent change for clearances of
creatinine and urea, respectively, at each of the four concentra-
tions of DSS. As can be seen from these figures, there were
substantial increases in clearance throughout exchanges 5
through 15, which were proportional to concentration.
The bar graph in Fig. 4 illustrates the average post-DSS
change in creatinine and urea clearances at each concentration.
Even at a concentration of 0.005% DSS, there was approxi-
mately a 75% increase in both creatinine clearance (P < 0.001)'
and urea clearance (P < 0.001). Clearance of creatinine contin-
ued to show statistically significant increases even at the 0.04%
concentration (P < 0.05) over the 0.02% concentration. In
contrast, the clearance of urea appeared to plateau with the
0.02% concentration at a mean percent change of approximate-
ly 150% relative to control clearance values.
Because only three rabbits were studied at each concentra-
tion, the relative influence of DSS concentration on clearances
was also determined by median data. Nonparametric analysis of
variance (Wilcoxon Rank Sum Test) also showed percent
increase in clearance grouped by concentration to be statistical-
ly significant (P < 0.001).
x 100% (2) 'ANOVA for paired samples (crossover design)
Animal
no.
mi/mm/kg
C urea
mi/rnin/kg
Wt
kg
concentration
%
Control
(Exchanges 1—4)
0.19
Post-DSS
(Exchanges 5—15)
Control
(Exchanges 1—4)
Post-DSS
(Exchanges 5—15)
1 2.33 0.005 0.25 0.15 0.26
2 2.65 0.005 014b 0.20 0.19 0.21
3 2.55 0.005 0.09 0.22 0.06
0.0 0.17 0.41 0.08 0.18
5 2.84 0.01 0.11 0.26 0.33 0.46
6 2.69 0.01 0.10 0.22 0.25 0.52
7 4.19 0.02 0mb 0.32 0.14 0.53
8 2.17 0.02 0.22 0.42 0.16 0.29
9 2.92 0.02 0.14 0.29 0.19
0.04 0.20 0.65 0.27 0.70
11 4.01 0.04 0.11 0.32 0.20 0.58
12 2.82 0.04 0.11 0.46 0.10 0.25
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Fig. 1. Influence of DSS on creatinine and urea clearance.
various concentrations prior to statistical analysis. According-
ly, the clearances of creatinine and urea during the control
period (exchanges 1 through 4) were used to calculate a mean
baseline for each rabbit. This value was then used to determine
the percent change in creatinine and urea clearances following
addition of DSS to the dialysate (post-DSS). Percent change in
clearance was thus defined as follows:
(post-DSS clearance) — (pre-DSS clearance)% change = (pre-DSS clearance)
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DSS concentration
% No. of rabbits
Ccr
mI/mm/kg
Cr
mi/mm/kg
0.005 3 0.23 0.01 0.21 0.01
0.01 3 0.30 0.02 0.39 0.03
0.02 3 0.34 0.02 0.39 0.02
0.04 3 0.48 0.04 0.51 0.04
Dialysis exchange
Fig. 2. influence of DSS on the clearance of creatinine.
The hydration state of the animals remained constant
throughout the procedure. Although we anticipated that the
wetting properties of DSS might promote an increased drainage
of dialysate fluid, analysis of the drainage volumes of all
animals revealed no significant change following DSS adminis-
tration. On the other hand, increases in dialysate creatinine and
urea concentrations essentially paralleled the changes in clear-
ance.
No changes in animal behavior were noted during cycles with
dialysis fluid containing DSS as compared with control fluid
alone. But some fibrinous material was noted in the dialysate
0.005% 0.0 1% 0.02% 0.04%
DSS concentration
Fig. 4. Change in creatinine and urea clearance following DSS addition
to dialysate. Each bar represents the mean response for all post-DSS
exchanges in 3 rabbits. Bars with different symbol numbers are signifi-
cantly different (P < 0.05).
drainage fluid of two animals receiving 0.04% DSS. Only trace
amounts were observed in the fluid from the other animals, and
no increase was noted in the post-DSS exchanges relative to the
initial control exchanges.
Discussion
Based on the results obtained from this study, it is evident
that DSS produces a significant increase in urea and creatinine
clearance. Following the addition of DSS to a single dialysis
exchange, the percent increase in creatinine clearance relative
to baseline values ranged from 74 to 244%, and urea clearance
increased by 79 to 166%. In addition to the overall increase in
solute clearance, the magnitude of the effect correlated with
increasing DSS concentrations, particularly so in the case of
creatinine. Furthermore, the addition of DSS to a single dialy-
sate exchange resulted in an increase in clearance that persisted
for the duration of the dialysis procedure without a return
toward baseline. Thus, the results of this study appear superior
to those produced by other accelerators with respect to both the
magnitude and the duration of the observed effect on clearance.
The mechanism of the DSS effect on promoting increases in
peritoneal solute clearance is unknown. Based on earlier work
exploring the potential of DSS as an accelerator, it was postu-
lated that the effect of DSS might be related to an alteration in
the structure of the peritoneal membrane due to the removal of
phospholipids. This proposal was based upon the recovery of a
significant quantity of phosphatides from dialysate return fluid
[31]. Further work is currently underway in this laboratory with
regard to the effect of DSS on membrane phospholipids.
The notable increases effected by DSS on urea clearance lead
to further speculation on the effects of DSS. Nolph and Sorkin
[33] recently proposed that the main limitations to urea clear-
ance are due to peritoneal interstitial resistance and stagnant or
unstirred dialysate fluid films, The ability of DSS to effect a
Table 2. Effect of DSS concentration on creatinine and urea
clearancesa
300 Creatinine
Urea
aBaseljfle creatinine and urea clearances for all 12 rabbits prior to
administration of DSS were 0.14 0.0! mI/mm/kg and 0.18 0.01 nil!
mm/kg, respectively. Clearances are the means SCM.
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Fig. 3. influence of DSS on the clearance of urea.
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